Evidence map›Paper›PMID 39720037›Full record

ArticleHeliyon2024

Comparative study on the biosynthesis of magnetite nanoparticles using

Azhin H Mohammed, Renjbar M Mhammedsharif, Parwin J Jalil, Sida M Mhammedsharif, Ahmed S Mohammed

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Azhin H MohammedPhysics Department, College of Education, University of Sulaimani, Kurdistan Region, Iraq.
Renjbar M MhammedsharifScientific Research Centre, Soran University, Kurdistan Region, Iraq.
Parwin J JalilScientific Research Centre, Soran University, Kurdistan Region, Iraq.
Sida M MhammedsharifScientific Research Centre, Soran University, Kurdistan Region, Iraq.
Ahmed S MohammedCivil Engineering Department, College of Engineering, University of Sulaimani, Kurdistan Region, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study compares magnetite (Fe3O4) nanoparticles synthesized using Aspergillus elegans extract versus commercially available magnetite nanoparticles, focusing on their efficacy in dye degradation. The biosynthesis of Fe3O4 nanoparticles using fungal extracts offers a sustainable and eco-friendly alternative to conventional chemical methods. The nanoparticles were characterized using various techniques, including UV-Vis spectroscopy, XRD, FTIR, SEM, TEM, DLS, zeta potential, and VSM analysis, to assess their structural, morphological, and magnetic properties. Results showed that fungus-mediated Fe3O4 nanoparticles were smaller, with an average size of 19.2 nm, and exhibited better crystallinity, surface functionalization, and colloidal stability than their commercial counterparts, which had an average size of 60 nm. Additionally, the fungal nanoparticles displayed superior magnetic properties with a saturation magnetization of 50 emu/g compared to 36 emu/g for commercial Fe3O4. The dye degradation potential of the nanoparticles was tested using methyl violet, methyl orange, and rose bengal dyes. Fungus-mediated Fe3O4 nanoparticles demonstrated higher dye removal efficiency than commercial Fe3O4, indicating enhanced catalytic activity due to their smaller size and larger surface area. This study highlights the potential of myco-synthesized Fe3O4 nanoparticles as effective agents for environmental remediation, particularly in removing of hazardous synthetic dyes from wastewater.

Indexed as

Aspergillus elegansCatalytic activityCharacterizationMagnetite nanoparticle

Identifiers

PMID39720037
PMCPMC11665457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.